Search by Drug Name or NDC

    NDC 62756-0460-64 Buprenorphine 8 mg/1 Details

    Buprenorphine 8 mg/1

    Buprenorphine is a SUBLINGUAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is BUPRENORPHINE HYDROCHLORIDE.

    Product Information

    NDC 62756-0460
    Product ID 62756-460_9d5581f6-00f0-4185-b139-e57484bdadf7
    Associated GPIs 65200010100780
    GCN Sequence Number 029313
    GCN Sequence Number Description buprenorphine HCl TAB SUBL 8 MG SUBLINGUAL
    HIC3 H3W
    HIC3 Description OPIOID WITHDRAWAL THERAPY AGENTS, OPIOID-TYPE
    GCN 64673
    HICL Sequence Number 001762
    HICL Sequence Number Description BUPRENORPHINE HCL
    Brand/Generic Generic
    Proprietary Name Buprenorphine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Buprenorphine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route SUBLINGUAL
    Active Ingredient Strength 8
    Active Ingredient Units mg/1
    Substance Name BUPRENORPHINE HYDROCHLORIDE
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
    DEA Schedule CIII
    Marketing Category ANDA
    Application Number ANDA201760
    Listing Certified Through 2024-12-31

    Package

    NDC 62756-0460-64 (62756046064)

    NDC Package Code 62756-460-64
    Billing NDC 62756046064
    Package 3 BLISTER PACK in 1 CARTON (62756-460-64) / 10 TABLET in 1 BLISTER PACK
    Marketing Start Date 2016-02-17
    NDC Exclude Flag N
    Pricing Information N/A